Literature DB >> 19887413

Neglected tropical diseases: moving beyond mass drug treatment to understanding the science.

Adel Mahmoud1, Elias Zerhouni.   

Abstract

Neglected tropical diseases (NTDs) represent a major health burden in many developing countries. To date, global efforts to control thirteen parasitic and bacterial infections that affect more than 1.4 billion people have relied on mass drug administration. This singular approach should now be expanded to a more comprehensive suite of tools including coordinated community-based programs, vector control, local training, education, and environmental change. In addition, an intensive basic research agenda is urgently needed to develop effective diagnostic, preventive, and therapeutic interventions to stay one step ahead of the evolutionary adaptation tactics of disease-causing microbes and parasites.

Entities:  

Mesh:

Year:  2009        PMID: 19887413     DOI: 10.1377/hlthaff.28.6.1726

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  9 in total

1.  Balance between clinical and environmental responses to infectious diseases.

Authors:  Justin V Remais; Joseph N S Eisenberg
Journal:  Lancet       Date:  2012-04-03       Impact factor: 79.321

Review 2.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni.

Authors:  Workineh Torben; Gul Ahmad; Weidong Zhang; Stewart Nash; Loc Le; Souvik Karmakar; Afzal A Siddiqui
Journal:  Vaccine       Date:  2012-09-20       Impact factor: 3.641

4.  Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.

Authors:  Vicente P Martins; Suellen B Morais; Carina S Pinheiro; Natan R G Assis; Barbara C P Figueiredo; Natasha D Ricci; Juliana Alves-Silva; Marcelo V Caliari; Sergio C Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2014-03-20

5.  Global burden, distribution, and interventions for infectious diseases of poverty.

Authors:  Zulfiqar A Bhutta; Johannes Sommerfeld; Zohra S Lassi; Rehana A Salam; Jai K Das
Journal:  Infect Dis Poverty       Date:  2014-07-31       Impact factor: 4.520

Review 6.  Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development.

Authors:  Barbara Castro-Pimentel Figueiredo; Natasha Delaqua Ricci; Natan Raimundo Gonçalves de Assis; Suellen Batistoni de Morais; Cristina Toscano Fonseca; Sergio Costa Oliveira
Journal:  Front Immunol       Date:  2015-01-28       Impact factor: 7.561

7.  Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.

Authors:  Barbara C Figueiredo; Natan R G Assis; Suellen B Morais; Natasha D Ricci; Carina S Pinheiro; Vicente P Martins; Rodrigo M Bicalho; Akram A Da'dara; Patrick J Skelly; Sergio C Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

8.  Funding patterns for biomedical research and infectious diseases burden in Gabon.

Authors:  Olouyomi Scherif Adegnika; Yabo Josiane Honkpehedji; Fabrice Mougeni Lotola; Selidji Todagbe Agnandji; Ayola Akim Adegnika; Bertrand Lell; Elisa Sicuri
Journal:  BMC Public Health       Date:  2021-11-24       Impact factor: 3.295

9.  A mechanistic model of snakebite as a zoonosis: Envenoming incidence is driven by snake ecology, socioeconomics and its impacts on snakes.

Authors:  Gerardo Martín; Joseph J Erinjery; Dileepa Ediriweera; H Janaka de Silva; David G Lalloo; Takuya Iwamura; Kris A Murray
Journal:  PLoS Negl Trop Dis       Date:  2022-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.